Menu Expand
Chemical Warfare Toxicology

Chemical Warfare Toxicology

Franz Worek | John Jenner | Horst Thiermann

(2016)

Additional Information

Book Details

Abstract

Despite ongoing efforts to prohibit the production, storage and use of chemical warfare agents recent world events highlight the enduring threat to the population from these agents. Research efforts in various countries have resulted in novel insights into chemical warfare toxicology that has enabled the development of new approaches for the diagnosis and treatment of chemical warfare poisoning. This book provides an up-to-date treatise on the ongoing research into the toxicology of chemical warfare agents, the diagnosis and verification of exposure, and the pre- and post-exposure treatment of poisoning. Focussing on the fundamentals of the toxicology of nerve agents and vesicants, this book will give the reader a comprehensive overview of the many different aspects of chemical warfare agent toxicology. The text will appeal to toxicologists, biochemists and weapons specialists working in industry and academia, and anyone with an interest in chemical warfare toxicology or exposure.
Experts covering the broad range of topics related to CWAs author the chapters of this book. The authors are regarded as authorities in the fields of toxicology and military medicine, presenting state-of-the-art information for academic, clinical and governmental audiences.
David Oliver

Table of Contents

Section Title Page Action Price
Cover Cover
Chemical Warfare Toxicology Volume 1: Fundamental Aspects i
Preface vii
References to Material in the National Archives ix
Contents xi
Chapter 1 - Development, Historical Use and Properties of Chemical Warfare Agents 1
1.1 Introduction 1
1.2 Brief History of CW 2
1.2.1 Prior to 1914 2
1.2.2 The 1914–18 War (WWI) 2
1.2.2.1 Overview 2
1.2.2.2 Irritants 3
1.2.2.3 Chlorine 3
1.2.2.4 Phosgene 3
1.2.2.5 Sulfur Mustard 4
1.2.2.6 Other Agents 4
1.2.3 The Inter-War Years 4
1.2.4 The 1939–1945 War (WWII) 5
1.2.5 Post WWII and the Cold War Years 6
1.2.6 The Middle East 7
1.2.7 Terrorism 8
1.2.8 Chemical Weapons Convention 8
1.3 Classification, Properties and Modes of Use of CW Agents 9
1.3.1 Classification 9
1.3.2 Physicochemical Properties 9
1.3.2.1 Gaseous and Liquid Agents 9
1.3.2.2 Solid Agents 11
1.3.3 Ease of Production 12
1.4 Main Classes of Chemical Agents 12
1.4.1 Lung Injurants (Choking Agents) 12
1.4.1.1 Chlorine 12
1.4.1.2 Phosgene and Diphosgene 13
1.4.1.3 Perfluoroisobutene 13
1.4.2 Blood Agents 13
1.4.2.1 Hydrogen Cyanide 13
1.4.2.2 Cyanogen Chloride 14
1.4.3 Vesicants (Blister Agents) 14
1.4.3.1 Sulfur Mustard 14
1.4.3.2 Nitrogen Mustards 15
1.4.3.3 Lewisite 16
1.4.4 Nerve Agents 16
1.4.4.1 Tabun and DFP 16
1.4.4.2 Sarin, Soman, Cyclosarin and 2-Methyl GF 17
1.4.4.3 V Agents 18
1.4.4.4 Other Nerve Agents 18
1.4.5 Riot Control Agents 19
1.4.6 Incapacitants 20
1.4.7 Future Developments 22
References 23
Chapter 2 - Toxicology of Vesicants 29
2.1 Introduction 29
2.2 Sulfur Mustard 30
2.2.1 Mechanism of Action 30
2.2.1.1 Chemical Reactivity 30
2.2.1.2 Alterations to DNA 31
2.2.1.3 Alterations to Other Cellular Components and Processes 32
2.2.2 Toxicokinetics, Metabolism and Distribution 32
2.2.2.1 Studies in Animals 33
2.2.2.1.1\rDermal.Cullumbine46 used a histological stain that formed an insoluble black complex with free SM, but not with degradation prod... 33
2.2.2.1.2\rInhalation.SM is readily absorbed across the respiratory tract, including across the nasal membrane.49 Langenberg et al.50 showe... 33
2.2.2.1.3\rOther Routes.Radioactivity appears in the kidney, lung and liver after intravenous administration of radiolabelled SM to the rab... 33
2.2.2.2 Studies in Humans 34
2.2.2.2.1 Dermal.Renshaw† reported that >80% of SM applied to the skin evaporates if the application site is left unoccluded,58 a... 34
2.2.2.2.2\rOther Routes of Exposure.No systematic studies describe the kinetics of SM following other routes of exposure in humans. In part... 34
2.2.2.3 In vitro Studies 36
2.2.3 Acute Toxicity 36
2.2.3.1 Studies in Animals 36
2.2.3.1.1\rOral Exposure.There are few reports on the oral toxicity of SM. In one study, the oral lethal dose, 50% (LD50) of SM [administer... 36
2.2.3.1.2\rDermal Exposure.Since the first research efforts in 1917–1918, a large range of animal species have been exposed to SM liquid an... 37
Lethality.Dacre and Goldman72 reported the percutaneous LD50 of SM to be 9 mg kg−1 in the rat, 92 mg kg−1 in the mouse, 20 mg kg... 37
Sublethal Pathology.Venkateswaran et al.74 investigated the systemic effects of sublethal percutaneous doses of SM (3.88, 7.75 o... 37
2.2.3.1.3\rInhalation 38
Pathology.An early study described the pathology of SM effects on the lungs in detail.75 Three groups of dogs responded in diffe... 38
Lethality by Inhalation.There are very few quantitative determinations of the lethality of SM after inhalation exposure. Box and... 39
2.2.3.2 Exposures of Humans 40
2.2.3.2.1\rDermal.The acute dermal effects of SM are a primary irritancy reaction and are covered in detail in Section 2.4 40
2.2.3.2.2\rInhalation.There are no non-anecdotal reports of acute effects in humans by the inhalation route. The following is an account of... 40
First World War.In a 1922, a clinical study of 83 “pensioners” with recognised disability due to gas poisoning during WWI was pe... 42
Second World War.There were no battlefield exposures to SM during combat in WWII. However, an example of the effects of an acute... 42
Iran–Iraq War.Over 100000 medical casualties were reported from the Iran–Iraq War with symptoms related to SM exposure. Of 61 vi... 43
2.2.4 Irritation and Corrosiveness 44
2.2.4.1 Studies in Animals 44
2.2.4.1.1\rDermal.Early studies97 described similar pathology of liquid SM on the skins of rabbits, guinea pigs and cats. Within 2 hours of... 44
2.2.4.1.2\rInhalation.Vijayaraghavan et al.83 investigated the effects of the inhalation of SM on breathing patterns in groups of four mice... 45
2.2.4.1.3\rOcular.Warthin103 compared clinical descriptions of SM induced eye lesions in humans with the pathology of experimental lesions ... 46
2.2.4.2 Studies in Humans 46
2.2.4.2.1\rDermal.SM produces a dose dependent primary irritant response, erythema, oedema and vesication/desquamation when it comes into c... 47
2.2.4.2.2\rOcular Effects.There are two key studies in human volunteers that quantify the effects of SM vapour on human eyes.106,107 Human ... 48
2.2.5 Sensitisation 48
2.2.5.1 Studies in Animals 48
2.2.5.2 Studies and Exposures in Humans 49
2.2.6 Repeated Dose Toxicity 49
2.2.6.1 Studies in Animals 49
2.2.6.1.1\rOral.Sasser et al.118 dosed male and female Sprague–Dawley rats (12 of each gender per dose group) with SM dissolved in sesame o... 49
2.2.6.1.2\rInhalation.McNamara et al.80 studied 6 dogs, 12 rabbits, 30 guinea pigs, 140 rats and 140 A/J mice, housed in a chamber and cont... 50
2.2.6.2 Studies in Humans 51
2.2.7 Mutagenicity 52
2.2.7.1 DNA Damage In vitro 52
2.2.7.2 Mutagenicity Studies In vitro 53
2.2.7.3 Mutagenicity Studies in Drosophila 53
2.2.7.4 In vivo Studies in Mammals 53
2.2.7.5 Studies in Humans 53
2.2.8 Carcinogenicity 54
2.2.8.1 Studies in Animals 54
2.2.8.1.1\rOral.Sasser et al.119 dosed male and female Sprague–Dawley rats as described in Section 2.6.1.1 at doses of 0 (control), 0.003, ... 54
2.2.8.1.2\rInhalation.Heston139 showed that exposure to SM vapour increased the incidence of pulmonary tumours in mice from an incidence of... 54
2.2.8.1.3\rOther Routes of Exposure.Heston141 described studies of the incidence of pulmonary tumours in mice treated intravenously with ni... 55
2.2.8.2 Studies in Humans 56
2.2.8.3 Conclusions for Carcinogenicity 57
2.2.9 Toxicity for Reproduction 58
2.2.9.1 Studies in Animals 58
2.2.9.1.1\rDevelopmental Toxicity.Rommereim and Hackett152 administered oral doses of SM at 0–2 mg kg−1 on gestation days 6–15 inclusive (r... 58
2.2.9.1.2\rFertility.In a 42 week two generation study in the rat,119 groups of 27 females and 20 males/group/generation were treated by ga... 58
2.2.9.2 Studies in Humans 59
2.2.10 Summary of SM Toxicology 60
2.3 Lewisite 60
2.3.1 Toxicokinetics 61
2.3.2 Acute Toxicity 62
2.3.2.1 Studies in Animals 62
2.3.2.2 Studies in Humans 64
2.3.3 Ocular Toxicity 65
2.3.4 Repeated Dose Toxicity 66
2.3.5 Mutagenicity 67
2.3.6 Toxicity for Reproduction 67
2.3.7 Summary of L Toxicology 68
2.4 Conclusions 68
Acknowledgements 69
References 69
Chapter 3 - Toxicology of Organophosphorus Nerve Agents 81
3.1 Introduction 81
3.2 General Substance Information 82
3.2.1 Physicochemical Properties 82
3.2.2 History 83
3.2.3 Uses 86
3.3 Hazard Characterization of Nerve Agents 86
3.3.1 Acute Effects of Nerve Agent Exposure 87
3.3.2 Historical Nerve Agent Toxicity Studies 88
3.3.2.1 Systemic Toxicity Studies 89
3.3.2.2 Vapour Exposures 93
3.3.2.3 Penetration of Skin and Clothing by Liquid Agents 98
3.3.3 Other Effects of Nerve Agent Exposure 100
3.3.4 Delayed and Long Term Effects of Nerve Agent Exposure 101
3.3.5 Effects of Low Level Nerve Agent Exposure 102
3.4 Human Estimates of Nerve Agent Toxicity 104
3.5 Summary 104
References 107
Chapter 4 - Toxicology and Treatment of Phosgene Induced Lung Injury 117
4.1 Introduction 117
4.2 Properties 119
4.2.1 Odour 119
4.2.2 Pathophysiology 119
4.2.2.1 Initial Reflex Syndrome 120
4.2.2.2 Clinical Latent Phase 121
4.2.2.3 Clinical Oedema Phase 122
4.3 History of Use 123
4.3.1 Warfare 123
4.3.2 Occupational/Accidental Exposures 124
4.4 Haber’s Law 125
4.5 Tolerance 127
4.6 Mechanisms of Phosgene Injury 128
4.7 Therapeutic Research Approaches 130
4.7.1 In vitro Studies 131
4.7.2 Small Animal In vivo Studies 134
4.7.3 Large Animal In vivo Studies 136
4.8 Recent Advances 141
4.8.1 Potential Future Therapeutic Options 143
4.8.1.1 Stem Cells 145
4.8.1.2 Growth Factors 145
4.9 Conclusions 146
Acknowledgements 147
References 147
Chapter 5 - Human Exposures to Sulfur Mustard 154
5.1 Introduction 154
5.2 Toxic Effects of SM in Humans 155
5.2.1 Effects on the Eyes 155
5.2.2 Effects on the Skin 158
5.2.2.1 Vapour 160
5.2.2.1.1\rExposure of the Forearm.Several groups have attempted to establish the threshold Ct for erythema in humans. The first systematic... 160
5.2.2.1.2\rWhole Body Exposures 161
Chamber Trials.In a series of chamber exposures carried out in India in 194240, men were exposed to Cts of SM from 40.9 to 176 m... 161
5.2.2.1.3\rQuantification of Skin Burns.There have been a number of attempts to devise methods of quantifying skin burns in terms of severi... 163
5.2.2.2 Effects of Increased Temperature on SM Injury 163
5.2.2.3 Effects of RH on SM Injury 164
5.2.2.4 Analytical Considerations 165
5.2.2.5 Clothing 166
5.2.2.5.1\rSystemic Poisoning after Vapour Exposure of the Skin.After the vapour exposures reported by Heinen et al.41 described above, no ... 167
5.2.2.6 Liquid 167
5.2.2.6.1\rPotency of SM on Human Skin and Sensitisation by Previous Exposure.In an early study, 302 workers at the UK defence establishmen... 169
5.2.2.6.2\rSensitisation.The observation from early studies that individuals who had been previously exposed to SM were more sensitive than... 172
5.3 Conclusions 173
References 175
Chapter 6 - Long-Term Effects of the Chemical Warfare Agent Sulfur Mustard 179
6.1 Introduction 179
6.2 Sulfur Mustard 180
6.2.1 Cutaneous Injury 181
6.2.2 Ocular Injury 183
6.2.3 Pulmonary Injury 185
6.2.4 Cancers 186
References 187
Chapter 7 - Toxicokinetics of Sulfur Mustard 191
7.1 Introduction 191
7.2 Experimental 193
7.2.1 Analytical Procedures 193
7.2.2 Animal Models 194
7.3 Toxicokinetics of Sulfur Mustard 195
7.3.1 Intravenous Toxicokinetics of Sulfur Mustard 195
7.3.1.1 Rat 196
7.3.1.2 Hairless Guinea Pig 197
7.3.1.3 Pig 199
7.3.1.4 Marmoset 199
7.3.2 Subcutaneous Toxicokinetics of Sulfur Mustard 200
7.3.2.1 Pig 200
7.3.3 Inhalation Toxicokinetics of Sulfur Mustard 201
7.3.3.1 Rat 201
7.3.3.2 Hairless Guinea Pig 202
7.3.3.3 Marmoset 203
7.3.4 Percutaneous Toxicokinetics of Sulfur Mustard 204
7.3.4.1 Pig 204
7.3.4.2 Hairless Guinea Pig 204
7.4 The Influence of Scavengers on the Toxicokinetics of Sulfur Mustard 206
7.5 Toxicokinetics of Sulfur Mustard in Humans 207
7.6 Conclusions 209
References 210
Chapter 8 - Modeling Organophosphorus Chemical Warfare Nerve Agents: A Physiologically Based Pharmacokinetic–Pharmacodynamic (PBPK-PD) Model of VX 213
8.1 Introduction 214
8.2 Materials and Methods 215
8.2.1 PBPK Model Structure 215
8.2.1.1 Routes 217
8.2.1.2 Endpoints 218
8.2.2 Model Parameters 218
8.2.2.1 Physiological Parameters 218
8.2.2.2 Chemical Specific Parameters 222
8.2.2.3 Pharmacodynamic Parameters 222
8.2.2.4 Dosing Parameters 222
8.2.3 Data Used for Model Parameterization and Validation 222
8.2.3.1 Intravenous Data 223
8.2.3.2 Subcutaneous Data 223
8.2.3.3 Dermal Data 223
8.2.4 Sensitivity Analyses 223
8.3 Results 224
8.3.1 Simulations 224
8.3.1.1 Data for Fitting 224
8.3.1.2 Data for Validation 224
8.3.2 Sensitivity Analyses 225
8.3.2.1 Sensitivity Analyses for the Intravenous Route 227
8.3.2.2 Sensitivity Analyses for the Subcutaneous Route 229
8.3.2.3 Sensitivity Analyses for the Dermal Route 230
8.4 Discussion 231
8.4.1 PBPK Model Structure 231
8.4.2 Model Parameters 251
8.4.3 Simulations 253
8.4.4 Sensitivity Analyses 254
8.5 Conclusions 258
Acknowledgements 258
References 259
Chapter 9 - Allometric Modeling of Mammalian Cyanogen Chloride Inhalation Lethality 264
9.1 Introduction 264
9.2 Statistical Background 265
9.2.1 Allometric Modeling and IH Toxicology 266
9.2.2 IH Dose–Response Statistics and the Toxic Load 268
9.2.3 Probit Analysis Models Used for Fitting Response Data 269
9.2.5 Healthy Subpopulation Versus General Population in Toxicity Sensitivity 271
9.3 CK: Properties and Characteristics 272
9.4 CK IH Toxicology 273
9.4.1 General Toxicology 274
9.4.2 Acute Human Toxicity 274
9.4.3 Acute Mammalian Toxicity 275
9.5 Previous Human Lethality Estimates for CK IH Toxicity 282
9.5.1 UK: Porton (Unofficial) 282
9.5.2 UK: Health Safety Executive 282
9.6 Data Analysis and Results 283
9.6.1 Data Reduction 283
9.6.1.1 Calculation and Collection of Nominal LD50s 283
9.6.1.2 Dataset Management for Probit Analysis 283
9.6.2 PS Estimation 284
9.6.3 Linear Regression Analysis 286
9.6.4 Allometric Scaling of Mammalian CK Lethality 288
9.6.5 TLE and Time–Concentration Relationship 290
9.6.6 Human Lethality Estimates for CK IH 291
9.6.7 Human Severe Effect Estimates for CK IH 291
9.6.8 Comparison of Estimates: Present Chapter with Previous Work 293
9.6.9 Comparison of CK and AC Human Lethality Estimates 294
9.6.10 Comparison of CK and AC Mammalian Lethality 295
9.7 Discussion and Conclusions 298
References 298
Subject Index 307